Unveiling the future of cell and gene therapies in the UK
In recent years, cell and gene therapies have been advancing at lightning speed, offering new hope to…
In recent years, cell and gene therapies have been advancing at lightning speed, offering new hope to…
Today the UK and EU agreed a deal for the UK to associate the world’s largest collaborative…
LifeArc is partnering with the Francis Crick Institute to invest £7.5m to support African scientists to address unmet…
LifeArc are partnering with Liverpool School of Tropical Medicine (LSTM) to launch a new development fund to…
LifeArc played an instrumental role in the drug’s development through our antibody humanisation work.
Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.
Catriona discusses why LifeArc is well placed to help overcome some of the obstacles in rare disease research
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures